
    
      It is a prospective interventional study arms parallel , active -controlled , non-inferiority
      . Participants selected for the study should be of both sexes , aged over 18 years and less
      than 65, which meet all the inclusion criteria and did not fit any exclusion criteria , and
      agree to all the purposes of the study. Participants are divided into two according to the
      randomization treatment groups 1:1.

      The study should take no longer than 30 days to be completed with the amount of 6 visits (7±2
      days): V0 radomization; V1, V2, V3 andV4(FV) are Evaluation visits and One Follow up visit
      7±2 days after the Final Visit.
    
  